Key result
Thrombospondins 1 and 2 interact with matrix metalloproteinase 2 and inhibit MMP activity, suggesting they may inhibit angiogenesis by preventing activation of MMP2 and MMP9 zymogens.
Population
Yeast two-hybrid system, tissue culture, and in vitro assays using purified intact TSP1, TSP2, MMP2, and MMP9
Design
Preclinical
Authors
Loading...
Hypothesis-generating for thrombospondin-MMP interactions in angiogenesis; leaves open translation to human cardiovascular disease.
Thrombospondins may inhibit angiogenesis by interacting with and preventing the activation of matrix metalloproteinases MMP2 and MMP9.
Bein et al. (2000) studied Angiogenesis. Thrombospondin 1 and 2 properdin-like type 1 repeats (TSR) was evaluated on Protein interaction and MMP activity. Thrombospondins 1 and 2 interact with matrix metalloproteinase 2 and inhibit MMP activity, suggesting they may inhibit angiogenesis by preventing activation of MMP2 and MMP9 zymogens.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: